Researchers Submit Patent Application, 'Treatment Of Serotonin Reuptake Inhibitor Withdrawal Syndrome', for Approval (USPTO 20240277654)

MLA

“Researchers Submit Patent Application, ’Treatment Of Serotonin Reuptake Inhibitor Withdrawal Syndrome’, for Approval (USPTO 20240277654).” Mental Health Weekly Digest, 9 Sept. 2024, p. 952. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.807698503&authtype=sso&custid=ns315887.

APA

Researchers Submit Patent Application, ’Treatment Of Serotonin Reuptake Inhibitor Withdrawal Syndrome’, for Approval (USPTO 20240277654). (2024, September 9). Mental Health Weekly Digest, 952.

Chicago

Mental Health Weekly Digest. 2024. “Researchers Submit Patent Application, ’Treatment Of Serotonin Reuptake Inhibitor Withdrawal Syndrome’, for Approval (USPTO 20240277654),” September 9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.807698503&authtype=sso&custid=ns315887.